<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/76CD45AC-378E-4073-94E5-C7DFBA3B4719"><gtr:id>76CD45AC-378E-4073-94E5-C7DFBA3B4719</gtr:id><gtr:name>University of Turku</gtr:name><gtr:address><gtr:line1>Turun yliopisto</gtr:line1><gtr:postCode>FI-20014</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/76CD45AC-378E-4073-94E5-C7DFBA3B4719"><gtr:id>76CD45AC-378E-4073-94E5-C7DFBA3B4719</gtr:id><gtr:name>University of Turku</gtr:name><gtr:address><gtr:line1>Turun yliopisto</gtr:line1><gtr:postCode>FI-20014</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/716F7466-6BCC-4815-8F7C-3572072BE8B5"><gtr:id>716F7466-6BCC-4815-8F7C-3572072BE8B5</gtr:id><gtr:firstName>Jie</gtr:firstName><gtr:surname>Na</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500491"><gtr:id>6EE57C16-68F1-4741-B04E-E894BCA8C6D4</gtr:id><gtr:title>The Function of Wnt Signalling during Human Embryonic Stem Cell Self-renewal and Neural Differentiation.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0500491</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Wnts are a family of glycoproteins that can regulate cell fate decisions and play important roles during embryogenesis. Several lines of evidence suggest that Wnt signalling is involved in the regulation of self-renewal and neural differentiation of human embryonic stem (hES) cells. However, little is known about the underlying molecular mechanism. This project aims to characterise in detail the level and the timing of Wnt signalling in undifferentiated human embryonic stem cells and during their neural differentiation using a fluorescent protein-Wnt reporter system as well as by examining the phosphorylation status of -catenin and Dishevelled proteins which are key transducers of the Wnt signals. To address the functional significance of Wnt pathway during the self-renewal of human embryonic stem cells, both the endogenous Wnt pathway activity and the impact of graded activation of Wnt signalling on the pluripotency, the growth condition and the differentiation potential of hES cells will be analysed. This will inform us the safe range of Wnt activity in undifferentiated human embryonic stem cells and the consequence of mis-regulation of Wnt signalling. To explore the roles Wnt signalling during neurogenesis, the dynamic regulation of Wnt pathway activities will be monitored throughout the course of induced neural differentiation. Moreover, through cell sorting according to the fluorescence of the Wnt reporter, I will collect cells at the window when peak Wnt activity occurs and identify the Wnt pathway members responsible for that. To confirm the functional importance of Wnt signalling during neurogenesis, I will use RNA interference to knock-down the highly expressed Wnt pathway members to examine the effect on neural differentiation. Finally, I will introduce a red fluorescence protein-Wnt reporter into genetically modified hES cells carrying a neural tissue-specific enhancer driving the expression of GFP and select different population of cells according to their colour of fluorescence and perform microarray to identify signalling pathways that may interact with Wnt signalling during hES cell neural differentiation. The research proposed in this study will shed important insights on the function of Wnt signalling in human embryonic stem cells and during their neurogenesis. They will also provide valuable information for the development of regenerative medicine for transplantation therapy in neurodegenerative disorders such as Alzheimer?s and Parkinson?s diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>174123</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biomedical Science</gtr:department><gtr:description>Reprogram Cell Fate using RNA</gtr:description><gtr:id>2ED3ADA5-CA03-43D1-82E2-5EA0D0095254</gtr:id><gtr:impact>We have presented our result in ESTOOLS meeting in Budapest Hungary 2008 and MRC iPSC meeting on 15Apr09. 
The data obtained from this work was written up as a paper and currently under revision for publication in PLoS ONE. 
Jordan R. Plews, Jian Liang Li, Peter W. Andrews, JIE NA* (*Corresponding author). Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach.</gtr:impact><gtr:outcomeId>6AC1BE3B23C-1</gtr:outcomeId><gtr:partnerContribution>Provide the base for this research.</gtr:partnerContribution><gtr:piContribution>I conceived the idea to use RNA to induce pluripotency and reprogram cell fate. cDNA constructs of 8 know reprograming factors were generated. We established protocol to introduce RNA into cells efficiently. The change in gene expression was measured by quantitative PCR and protein marker immunostaining.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Turku</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>Turku Centre for Biotechnology</gtr:department><gtr:description>Identify canonical Wnt signalling pathway target genes during human ES cell differentiation</gtr:description><gtr:id>38110956-A363-4D64-B3E0-B72E1AD4369A</gtr:id><gtr:impact>The microarray data was deposited in the public database.
We are preparing a manuscript for publication.</gtr:impact><gtr:outcomeId>tZ72zig97bL-1</gtr:outcomeId><gtr:partnerContribution>My collaborator has performed the Illumina microarray.</gtr:partnerContribution><gtr:piContribution>We conceived the idea of the collaboration and produced sample for microarray analysis. Currently, we are analysing microarray data and prepare manuscript for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>&quot;Smile of a Stem Cell&quot; exhibition</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>FF8BB23E-3A0E-4393-8B90-26A50C172014</gtr:id><gtr:impact>Exhibition of stem cell images, to give the general public some basic information about what is stem cell, their potential and challenges in research and regenerative medicine.

Make general public more aware of our research goals and activities. Very positive impact.</gtr:impact><gtr:outcomeId>8BBAC1E3886</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Royal Society Research Grant</gtr:description><gtr:end>2008-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>41C10119-E240-4AB1-97EF-44616200C8E6</gtr:id><gtr:outcomeId>E43A0BEC1290</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The VIP grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CC41E843-07E9-4CED-A1C6-D14B64BF8378</gtr:id><gtr:outcomeId>EC61429C53D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Master course for Stem Cells and Regenerative Medicine</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>09717DDD-854B-4ABE-A6D4-B4B9F33082AE</gtr:id><gtr:impact>Give students up-to-date knowledge and some lab experience working on stem cells.</gtr:impact><gtr:outcomeId>017B210794A</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>RNA from human embryonic stem cells</gtr:description><gtr:id>5EC25864-4BE6-4994-AF01-8963BF625BFF</gtr:id><gtr:impact>Identified novel responsive genes of Wnt and FGF signalling.</gtr:impact><gtr:outcomeId>FE5AF9CBD78</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray data set</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>28AC222A-B558-4652-927E-D3C9E01843CA</gtr:id><gtr:title>Inhibition of ERK1/2 prevents neural and mesendodermal differentiation and promotes human embryonic stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b17707820da8c0303ca8ff697aec7f7"><gtr:id>6b17707820da8c0303ca8ff697aec7f7</gtr:id><gtr:otherNames>Na J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>ADyD3LCEjmR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>334A147E-BAA0-4ECD-A1AC-1208973D0E6F</gtr:id><gtr:title>Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cff9ba49635dbcd0bce5585c152bb68"><gtr:id>6cff9ba49635dbcd0bce5585c152bb68</gtr:id><gtr:otherNames>Plews JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>P2sBmAn3NnG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>954B2C1A-F837-4526-924A-AFFD5399E8E3</gtr:id><gtr:title>Molecular mechanisms of pluripotency and reprogramming.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b17707820da8c0303ca8ff697aec7f7"><gtr:id>6b17707820da8c0303ca8ff697aec7f7</gtr:id><gtr:otherNames>Na J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>RL93gxfPUjL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73319D34-47E1-4DCE-B809-EDE7A0374470</gtr:id><gtr:title>Advantages and difficulties in culturing human pluripotent stem cells in growth factor-defined serum-free medium.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ac1ea761762fa7c7cba02e54c87cf88"><gtr:id>5ac1ea761762fa7c7cba02e54c87cf88</gtr:id><gtr:otherNames>Kusuda Furue M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>CRNoj2J48G6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3C13FE5-C8CA-4331-B3B9-52303D24B58A</gtr:id><gtr:title>Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5595022016a4a1c3f702d2689191724"><gtr:id>a5595022016a4a1c3f702d2689191724</gtr:id><gtr:otherNames>Furue MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5AE0361FB96</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500491</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>